Matches in Nanopublications for { ?s ?p "[Multicentric study underlining the interest of adding CD5, CD7 and CD56 expression assessment to the flow cytometric Ogata score in myelodysplastic syndromes and myelodysplastic/myeloproliferative neoplasms.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 5 of
5
with 100 items per page.
- assertion description "[Multicentric study underlining the interest of adding CD5, CD7 and CD56 expression assessment to the flow cytometric Ogata score in myelodysplastic syndromes and myelodysplastic/myeloproliferative neoplasms.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Multicentric study underlining the interest of adding CD5, CD7 and CD56 expression assessment to the flow cytometric Ogata score in myelodysplastic syndromes and myelodysplastic/myeloproliferative neoplasms.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP1259700.RATTgutJB2ezdENPlwSISKpVB4dMswImy8-AlkLq6ge9U130_assertion description "[Multicentric study underlining the interest of adding CD5, CD7 and CD56 expression assessment to the flow cytometric Ogata score in myelodysplastic syndromes and myelodysplastic/myeloproliferative neoplasms.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1259700.RATTgutJB2ezdENPlwSISKpVB4dMswImy8-AlkLq6ge9U130_provenance.
- NP1259699.RAglnEBXVJECFv0hhN_afO-8Q5S9LstMZR1EoRaqnB9nU130_assertion description "[Multicentric study underlining the interest of adding CD5, CD7 and CD56 expression assessment to the flow cytometric Ogata score in myelodysplastic syndromes and myelodysplastic/myeloproliferative neoplasms.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1259699.RAglnEBXVJECFv0hhN_afO-8Q5S9LstMZR1EoRaqnB9nU130_provenance.
- NP1259702.RANHe9OAhPlovtksRzVZKUipdTMUEwnws1tLYcqE2JVp0130_assertion description "[Multicentric study underlining the interest of adding CD5, CD7 and CD56 expression assessment to the flow cytometric Ogata score in myelodysplastic syndromes and myelodysplastic/myeloproliferative neoplasms.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1259702.RANHe9OAhPlovtksRzVZKUipdTMUEwnws1tLYcqE2JVp0130_provenance.